Cargando…
Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer
Liver cancer has high incidence and mortality rates and its treatment generally requires the use of a combination treatment strategy. Therefore, the early detection and diagnosis of liver cancer is crucial to achieving the best treatment effect. In addition, it is imperative to explore multimodal co...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608862/ https://www.ncbi.nlm.nih.gov/pubmed/37894483 http://dx.doi.org/10.3390/molecules28207004 |
_version_ | 1785127878050971648 |
---|---|
author | Han, Qinghe Du, Lianze Zhu, Lili Yu, Duo |
author_facet | Han, Qinghe Du, Lianze Zhu, Lili Yu, Duo |
author_sort | Han, Qinghe |
collection | PubMed |
description | Liver cancer has high incidence and mortality rates and its treatment generally requires the use of a combination treatment strategy. Therefore, the early detection and diagnosis of liver cancer is crucial to achieving the best treatment effect. In addition, it is imperative to explore multimodal combination therapy for liver cancer treatment and the synergistic effect of two liver cancer treatment drugs while preventing drug resistance and drug side effects to maximize the achievable therapeutic effect. Gold nanoparticles are used widely in applications related to optical imaging, CT imaging, MRI imaging, biomarkers, targeted drug therapy, etc., and serve as an advanced platform for integrated application in the nano-diagnosis and treatment of diseases. Dual-drug-delivery nano-diagnostic and therapeutic agents have drawn great interest in current times. Therefore, the present report aims to review the effectiveness of dual-drug-delivery nano-diagnostic and therapeutic agents in the field of anti-tumor therapy from the particular perspective of liver cancer diagnosis and treatment. |
format | Online Article Text |
id | pubmed-10608862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106088622023-10-28 Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer Han, Qinghe Du, Lianze Zhu, Lili Yu, Duo Molecules Review Liver cancer has high incidence and mortality rates and its treatment generally requires the use of a combination treatment strategy. Therefore, the early detection and diagnosis of liver cancer is crucial to achieving the best treatment effect. In addition, it is imperative to explore multimodal combination therapy for liver cancer treatment and the synergistic effect of two liver cancer treatment drugs while preventing drug resistance and drug side effects to maximize the achievable therapeutic effect. Gold nanoparticles are used widely in applications related to optical imaging, CT imaging, MRI imaging, biomarkers, targeted drug therapy, etc., and serve as an advanced platform for integrated application in the nano-diagnosis and treatment of diseases. Dual-drug-delivery nano-diagnostic and therapeutic agents have drawn great interest in current times. Therefore, the present report aims to review the effectiveness of dual-drug-delivery nano-diagnostic and therapeutic agents in the field of anti-tumor therapy from the particular perspective of liver cancer diagnosis and treatment. MDPI 2023-10-10 /pmc/articles/PMC10608862/ /pubmed/37894483 http://dx.doi.org/10.3390/molecules28207004 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Han, Qinghe Du, Lianze Zhu, Lili Yu, Duo Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer |
title | Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer |
title_full | Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer |
title_fullStr | Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer |
title_full_unstemmed | Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer |
title_short | Review of the Application of Dual Drug Delivery Nanotheranostic Agents in the Diagnosis and Treatment of Liver Cancer |
title_sort | review of the application of dual drug delivery nanotheranostic agents in the diagnosis and treatment of liver cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608862/ https://www.ncbi.nlm.nih.gov/pubmed/37894483 http://dx.doi.org/10.3390/molecules28207004 |
work_keys_str_mv | AT hanqinghe reviewoftheapplicationofdualdrugdeliverynanotheranosticagentsinthediagnosisandtreatmentoflivercancer AT dulianze reviewoftheapplicationofdualdrugdeliverynanotheranosticagentsinthediagnosisandtreatmentoflivercancer AT zhulili reviewoftheapplicationofdualdrugdeliverynanotheranosticagentsinthediagnosisandtreatmentoflivercancer AT yuduo reviewoftheapplicationofdualdrugdeliverynanotheranosticagentsinthediagnosisandtreatmentoflivercancer |